financetom
Business
financetom
/
Business
/
Boeing, Spirit AeroSystems execs to testify at NTSB hearing on MAX 9 emergency
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Boeing, Spirit AeroSystems execs to testify at NTSB hearing on MAX 9 emergency
Aug 5, 2024 8:55 AM

WASHINGTON (Reuters) - The National Transportation Safety Board said a number of Boeing and Spirit AeroSystems executives will testify at a two-day hearing starting Tuesday on the January Alaska Airlines Boeing 737 MAX 9 in-flight door plug emergency.

Boeing's senior vice president for quality Elizabeth Lund and Doug Ackerman, vice president of supplier quality for Boeing are among those that will testify as will Terry George, senior vice president and general manager for Boeing Program at Spirit AeroSystems, the NTSB said. Several Federal Aviation Administration officials will also testify.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Walker & Dunlop Arranges $356 Million for Boston Area Portfolio
Walker & Dunlop Arranges $356 Million for Boston Area Portfolio
Oct 8, 2025
BETHESDA, Md.--(BUSINESS WIRE)-- Walker & Dunlop, Inc. ( WD ) announced today that it arranged $356,411,000 in financing for the acquisition of four properties, all located within prominent New England MSAs. Walker & Dunlop Capital Markets, led by Craig West and team, arranged the portfolio financing on behalf of an affiliate longtime client, Harbor Group International, with Freddie Mac providing...
Zenas Bio inks potential $2 billion licensing deal with China's InnoCare for autoimmune drug
Zenas Bio inks potential $2 billion licensing deal with China's InnoCare for autoimmune drug
Oct 8, 2025
Oct 8 (Reuters) - Zenas BioPharma ( ZBIO ) said on Wednesday it has secured global rights to develop and commercialize an experimental drug from China-based InnoCare Pharma for multiple sclerosis and other autoimmune conditions under a licensing deal potentially worth more than $2 billion. The deal grants Zenas worldwide rights to the drug, orelabrutinib, outside oncology. The U.S.-based drug...
Update: Alpha Modus Sues Johnson Controls Over AI Patent Claims
Update: Alpha Modus Sues Johnson Controls Over AI Patent Claims
Oct 8, 2025
05:16 AM EDT, 10/08/2025 (MT Newswires) -- (Updates with Johnson Controls' ( JCI ) response in fourth paragraph.) Alpha Modus Holdings ( AMOD ) said its subsidiary filed a patent infringement lawsuit in federal court in Texas against Johnson Controls International ( JCI ) and its Sensormatic Electronics unit. A separate suit targets Navori of Switzerland and meldCX of Australia,...
Lithium Americas Finalizes Amendments to $2.23 Billion DOE Loan for Thacker Pass Project; Shares Up Pre-Bell
Lithium Americas Finalizes Amendments to $2.23 Billion DOE Loan for Thacker Pass Project; Shares Up Pre-Bell
Oct 8, 2025
05:59 AM EDT, 10/08/2025 (MT Newswires) -- Lithium Americas ( LAC ) said late Tuesday it finalized certain amendments to the company's $2.23 billion loan from the US Department of Energy for financing the construction of processing facilities at the Thacker Pass joint venture project with General Motors ( GM ) . The DOE has agreed to defer $184 million...
Copyright 2023-2026 - www.financetom.com All Rights Reserved